Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion type Assertion NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_head.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion description "[GnRHa therapy resulted in lowering of TGF-betaRs as well as Smad4 and pSmad3, with concurrent increased in Smad7 expression in both leiomyoma and myometrium compared to untreated group (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_provenance.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion evidence source_evidence_literature NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_provenance.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion SIO_000772 14604812 NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_provenance.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion wasDerivedFrom befree-2016 NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_provenance.
- NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_assertion wasGeneratedBy ECO_0000203 NP419612.RASisz1uaaBbcq5lbuJNr6khL-gZL_bSq92-sxxf7Z2Jo130_provenance.